Holen Sie sich die Stockscreener-App
0.00
100.00%
-0.157
Schlusskurs vom Vortag:
$0.157
Offen:
$0
24-Stunden-Volumen:
0
Relative Volume:
0.00
Marktkapitalisierung:
$11.00M
Einnahmen:
$1.16M
Nettoeinkommen (Verlust:
$-39.74M
KGV:
0.00
EPS:
-0.62
Netto-Cashflow:
$-35.02M
1W Leistung:
-100.00%
1M Leistung:
-100.00%
6M Leistung:
-100.00%
1J Leistung:
-100.00%
1-Tages-Spanne:
$0.00
$0.00
1-Wochen-Bereich:
$0.00
$0.00
52-Wochen-Spanne:
$0.00
$0.4477
Glycomimetics Inc Stock (GLYC) Company Profile
Firmenname
Glycomimetics Inc
Sektor
Branche
Telefon
240-243-1201
Adresse
9708 MEDICAL CENTER DRIVE, ROCKVILLE, MD
Vergleichen Sie GLYC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
GLYC
Glycomimetics Inc
|
0.00 | 11.00M | 1.16M | -39.74M | -35.02M | -0.62 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Glycomimetics Inc Stock (GLYC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-25 | Eingeleitet | Jefferies | Buy |
| 2025-08-11 | Eingeleitet | H.C. Wainwright | Buy |
| 2025-07-14 | Eingeleitet | Wedbush | Outperform |
| 2025-06-25 | Eingeleitet | Stifel | Buy |
| 2025-03-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-07-26 | Herabstufung | TD Cowen | Buy → Hold |
| 2023-12-22 | Eingeleitet | CapitalOne | Overweight |
| 2021-11-12 | Hochstufung | Jefferies | Hold → Buy |
| 2019-11-14 | Eingeleitet | ROTH Capital | Buy |
| 2019-08-05 | Herabstufung | Jefferies | Buy → Hold |
| 2019-08-05 | Herabstufung | Piper Jaffray | Overweight → Neutral |
| 2019-08-05 | Herabstufung | SunTrust | Buy → Hold |
| 2019-04-12 | Eingeleitet | Piper Jaffray | Overweight |
| 2018-12-18 | Eingeleitet | H.C. Wainwright | Buy |
| 2016-07-26 | Eingeleitet | SunTrust | Buy |
| 2015-03-17 | Bestätigt | Stifel | Buy |
Alle ansehen
Glycomimetics Inc Aktie (GLYC) Neueste Nachrichten
Identifying reversal signals in GlycoMimetics Inc.July 2025 Earnings & Low Risk Entry Point Guides - newser.com
GlycoMimetics Inc. stock prediction for this weekEarnings Summary Report & Daily Oversold Stock Bounce Ideas - newser.com
Long term hold vs stop loss in GlycoMimetics Inc.July 2025 Intraday Action & Daily Stock Trend Reports - newser.com
Predicting GlycoMimetics Inc. trend using moving averages2025 Retail Activity & Reliable Trade Execution Plans - newser.com
How interest rate cuts could boost GlycoMimetics Inc. stock2025 Volatility Report & Weekly Consistent Profit Watchlists - newser.com
How to forecast GlycoMimetics Inc. trends using time series2025 Bull vs Bear & Verified Entry Point Signals - newser.com
What machine learning models say about GlycoMimetics Inc.Market Risk Analysis & Safe Entry Zone Tips - newser.com
Best data tools to analyze GlycoMimetics Inc. stockTrade Signal Summary & Growth Oriented Trading Recommendations - newser.com
Why GlycoMimetics Inc. stock remains undervaluedGap Down & Stock Timing and Entry Methods - newser.com
Real time pattern detection on GlycoMimetics Inc. stockWeekly Trend Recap & High Accuracy Swing Trade Signals - newser.com
Earnings visualization tools for GlycoMimetics Inc.2025 Geopolitical Influence & Real-Time Chart Pattern Alerts - newser.com
Is GlycoMimetics Inc. stock attractive for growth ETFs2025 Investor Takeaways & Verified Trade Idea Suggestions - newser.com
Published on: 2025-10-31 00:29:32 - newser.com
Cantor Fitzgerald Initiates Coverage of GlycoMimetics (GLYC) with Overweight Recommendation - MSN
How GlycoMimetics Inc. stock compares to growth peers2025 Growth vs Value & Step-by-Step Swing Trade Plans - fcp.pa.gov.br
Published on: 2025-10-27 20:15:28 - newser.com
Can GlycoMimetics Inc. stock deliver surprise earnings beatMarket Risk Analysis & Reliable Price Breakout Alerts - Fundação Cultural do Pará
Finanzdaten der Glycomimetics Inc-Aktie (GLYC)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.64%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):